Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy (Q44748014)

5 December 2017

Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy (English)

1 reference

5 December 2017

12

1 reference

5 December 2017

Chi-Fen Chang

1

1 reference

5 December 2017

Jiunn-Bey Pao

2

1 reference

5 December 2017

Chia-Cheng Yu

3

1 reference

5 December 2017

Chao-Yuan Huang

4

1 reference

5 December 2017

Shu-Pin Huang

5

1 reference

5 December 2017

Ying-Pi Yang

6

1 reference

5 December 2017

Chun-Nung Huang

7

1 reference

5 December 2017

Ta-Yuan Chang

8

1 reference

5 December 2017

Bang-Jau You

9

1 reference

5 December 2017

Hong-Zin Lee

10

1 reference

5 December 2017

Tzyh-Chyuan Hour

11

1 reference

5 December 2017

10 February 2013

1 reference

Annals of Surgical Oncology

5 December 2017

1 reference

5 December 2017

20

1 reference

5 December 2017

7

1 reference

5 December 2017

2446-2452

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-013-2884-y

5 December 2017

0 references

cites work

Insulin-like growth factors and neoplasia.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Genetic variation in insulin-like growth factors and brain tumor risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Translational control by the 3'-UTR: the ends specify the means.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Interaction of IGF signaling and the androgen receptor in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Insulin-like growth factors and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2884-Y

10.1245/S10434-013-2884-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

5 December 2017

0 references

1 reference